7-hydroxystaurosporine has been researched along with ATLL in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batova, A; Bridgeman, LJ; Chang, RC; de Wit, E; Diccianni, MB; Kung, FH; Omura-Minamisawa, M; Pullen, JD; Yu, AL; Yu, J | 1 |
1 other study(ies) available for 7-hydroxystaurosporine and ATLL
Article | Year |
---|---|
In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxystaurosporine) is dependent on p16 protein status: a Pediatric Oncology Group study.
Topics: Alkaloids; Antineoplastic Agents; Carrier Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Gene Deletion; Gene Expression Regulation, Leukemic; Gene Silencing; Humans; Leukemia-Lymphoma, Adult T-Cell; Phosphorylation; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; Staurosporine; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2000 |